The results from the first three PDXs in the series suggest that loss of BRCA1 methylation can occur shortly after a single exposure to chemotherapy in the patient, and that the resultant cancers progressively increase BRCA1 expression after successive chemotherapeutic exposures. Here, BRCA1 is linked to cancer.